Your browser is no longer supported. Please, upgrade your browser.
AMGN Amgen Inc. daily Stock Chart
Amgen Inc.
IndexS&P 500 P/E14.15 EPS (ttm)12.60 Insider Own0.10% Shs Outstand633.30M Perf Week-5.18%
Market Cap112.92B Forward P/E11.96 EPS next Y14.90 Insider Trans-4.20% Shs Float614.67M Perf Month-4.44%
Income8.39B PEG7.07 EPS next Q3.48 Inst Own82.00% Short Float1.76% Perf Quarter-11.54%
Sales23.75B P/S4.76 EPS this Y14.80% Inst Trans0.11% Short Ratio3.57 Perf Half Y-11.65%
Book/sh19.62 P/B9.09 EPS next Y5.71% ROA12.30% Target Price207.38 Perf Year2.08%
Cash/sh46.27 P/C3.85 EPS next 5Y2.00% ROE58.50% 52W Range165.22 - 210.19 Perf YTD-8.41%
Dividend5.80 P/FCF16.01 EPS past 5Y13.70% ROI19.60% 52W High-15.17% Beta1.18
Dividend %3.25% Quick Ratio2.60 Sales past 5Y4.90% Gross Margin82.70% 52W Low7.92% ATR3.65
Employees21500 Current Ratio2.80 Sales Q/Q7.40% Oper. Margin43.20% RSI (14)32.78 Volatility2.70% 1.78%
OptionableYes Debt/Eq2.71 EPS Q/Q18.80% Profit Margin35.30% Rel Volume0.89 Prev Close179.76
ShortableYes LT Debt/Eq2.36 EarningsApr 30 AMC Payout41.60% Avg Volume3.03M Price178.30
Recom2.30 SMA20-5.60% SMA50-5.29% SMA200-8.15% Volume2,711,618 Change-0.81%
Jan-28-19Downgrade Evercore ISI Outperform → In-line
Oct-01-18Initiated Cantor Fitzgerald Neutral $223
Apr-05-18Reiterated Barclays Equal Weight $190 → $180
Feb-12-18Reiterated Mizuho Buy $192 → $200
Jan-23-18Upgrade Argus Hold → Buy
Nov-01-17Downgrade Argus Buy → Hold
Oct-26-17Reiterated RBC Capital Mkts Sector Perform $192 → $188
Sep-28-17Reiterated Mizuho Buy $183 → $198
Sep-15-17Initiated RBC Capital Mkts Sector Perform $192
Jul-11-17Resumed Jefferies Buy
Jun-23-17Initiated Deutsche Bank Hold $172
Apr-05-17Downgrade Jefferies Buy → Hold
Mar-09-17Initiated UBS Neutral $185
Feb-01-17Upgrade BofA/Merrill Neutral → Buy
Dec-20-16Downgrade Credit Suisse Outperform → Neutral
Dec-13-16Initiated Oppenheimer Outperform
Nov-08-16Initiated Mizuho Buy $164
Aug-26-16Initiated Gabelli & Co Hold
Jun-29-16Initiated Bernstein Mkt Perform
Feb-25-16Initiated Citigroup Neutral $165
Apr-24-19 04:29PM  Pfizer (PFE) to Report Q1 Earnings: Will It Beat Estimates? Zacks
04:04PM  Will Biotech ETFs Continue to Rally in Q1 Earnings? Zacks
01:50PM  AbbVie and Bristol-Myers Squibb will report first-quarter earnings on Thursday. Heres what to expect MarketWatch
10:02AM  Novartis (NVS) Q1 Earnings Beat Estimates, Revenues Up Y/Y Zacks
07:15AM  How Do Analysts See Amgen Inc. (NASDAQ:AMGN) Performing In The Next 12 Months? Simply Wall St.
Apr-23-19 10:59AM  Amgen (AMGN) to Report Q1 Earnings: What's in the Cards? Zacks
10:32AM  Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-22-19 05:55AM  Pfizer Stock Suffers From an Underappreciated Drugs Pipeline InvestorPlace
Apr-21-19 09:00AM  Amgen: This Beaten Down Blue Chip Is Priced To Own
Apr-19-19 08:02AM  Health-care drama has now spread to biopharma stocks MarketWatch
Apr-18-19 11:12PM  The Top 10 Biotechnology Companies (JNJ, ROG.VX) Investopedia
10:59AM  Can Q1 Earnings Lift Healthcare ETFs Higher? Zacks
07:26AM  3 Big Stock Charts for Thursday: Citrix Systems, Goldman Sachs Group and Amgen InvestorPlace
Apr-17-19 04:00PM  Amgen Foundation Launches Amgen Biotech Experience In Tampa, Florida PR Newswire
10:06AM  Amgen Falls 3%
Apr-16-19 06:54PM  Radius Health (RDUS) Rallies 33.4% YTD on Robust Tymlos Sales Zacks
10:52AM  Why Amgen Stock Could Break Out to New Highs InvestorPlace
Apr-15-19 04:03PM  Amgen sets $21,900 annual price for new Evenity bone drug Reuters
04:00PM  EVENITY (romosozumab-aqqg) Now Available In The United States For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture PR Newswire
09:56AM  The Zacks Analyst Blog Highlights: Bank of America, Amgen, NextEra, T-Mobile and S&P Global Zacks
06:58AM  Goldman Sachs's 20 best stocks to invest in now Yahoo Finance
Apr-13-19 12:28PM  Better Buy: Amgen vs. Gilead Sciences Motley Fool
09:38AM  The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs Benzinga
Apr-12-19 01:45PM  Top Analyst Reports for Bank of America, Amgen & NextEra Energy Zacks
11:08AM  Merck's Keytruda Gets FDA Nod for Expanded Lung Cancer Group Zacks
07:06AM  8 Stocks May Jump on Takeovers as Market Nears Peak Investopedia
Apr-11-19 05:31AM  8 Stocks to Own in 2Q as the Market Enters Rough Waters Investopedia
Apr-10-19 10:30AM  Akebia Expands Vadadustat Licensing Deal With Vifor Pharma Zacks
10:16AM  Amgen's (AMGN) Osteoporosis Drug Evenity Gets FDA Approval Zacks
09:44AM  Second Time's The Charm For Amgen As FDA OKs Bone-Building Osteoporosis Drug Benzinga
09:20AM  Biotech Stock Roundup: AMGN's Evenity Earns FDA Approval, Deal Wins & More Zacks
07:32AM  The Daily Biotech Pulse: Amgen's Bone-Building Osteoporosis Drug Clears FDA Muster, PhaseBio Offering Benzinga
Apr-09-19 05:16PM  Amgen's postmenopausal osteoporosis drug gets FDA greenlight Reuters
04:48PM  Amgen's postmenopausal osteoporosis drug gets FDA greenlight Reuters
04:09PM  FDA approves Amgen's Evenity for treatment of osteoporosis in postmenopausal women MarketWatch
03:57PM  FDA Approves EVENITY (romosozumab-aqqg) For The Treatment Of Osteoporosis In Postmenopausal Women At High Risk For Fracture PR Newswire
01:23PM  Here's Why Novartis Is Sliding Today Motley Fool
10:52AM  Why bluebird bio Could Deliver Miracles to Genetic Disease Patients Motley Fool
10:23AM  Why Amgen Can Deliver Medical and Financial Miracles Motley Fool
09:53AM  5 Stocks in the Age of Miracles Motley Fool
Apr-08-19 07:48AM  Lawsuit over migraine deal could be good for Amgen, analysts say MarketWatch
Apr-07-19 06:31PM  Why Amgen's Giving Novartis a Headache Motley Fool
05:00AM  Amgen Presents New Data At WCO-IOF-ESCEO 2019 Revealing Osteoporosis Treatment Gap In Europe PR Newswire
Apr-05-19 10:14AM  Novartis & Amgen in Legal Dispute Over Migraine Drug Aimovig Zacks
10:10AM  Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again Zacks
09:33AM  Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine Deal Investor's Business Daily
07:48AM  The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership Benzinga
Apr-04-19 05:16PM  Novartis, Amgen in dispute over migraine drug partnership Reuters
11:35AM  Novartis sues Amgen over migraine treatment Aimovig Reuters
10:26AM  Pfizer's New Lung Cancer Drug Vizimpro Gets EU Approval Zacks
09:39AM  Novartis Resubmits BLA to FDA for Biosimilar of Neulasta Zacks
Apr-03-19 12:00AM  Oxford Nanopores flotation plans are a boon for Neil Woodford Financial Times
Apr-02-19 09:36AM  Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe Zacks
Apr-01-19 07:06AM  Does Amgen Inc.'s (NASDAQ:AMGN) P/E Ratio Signal A Buying Opportunity? Simply Wall St.
07:02AM  BMOs Got A Point About Teva Stock, But Are Investors Willing To Listen? InvestorPlace
Mar-30-19 12:00PM  3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop Motley Fool
Mar-29-19 10:36AM  4 Small Biotech Stocks Likely to Witness More Upside in 2019 Zacks
Mar-28-19 05:44PM  AbbVie's big acquisition blowup: A one-off or an omen? American City Business Journals
Mar-27-19 10:55AM  Biotech Stock Roundup: BIIB & CNAT Crash on Study Failures, LXRX Gets CRL Zacks
09:16AM  The Zacks Analyst Blog Highlights: Apple, Amgen, United Technologies, Travelers and Xilinx Zacks
Mar-26-19 02:04PM  Top Research Reports for Apple, Amgen & United Technologies Zacks
11:18AM  AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan Zacks
11:01AM  Were Hedge Funds Right About Amgen, Inc. (AMGN)? Insider Monkey
07:50AM  New Research Coverage Highlights Amgen, Alarm, Werner Enterprises, Churchill Downs, Markel, and AAR Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Mar-25-19 10:53AM  S&P 500 Q4 2018 Buybacks Set 4th Consecutive Quarterly Record at $223 Billion; 2018 Sets Record $806 Billion PR Newswire
Mar-22-19 10:20AM  Biogen Stock Fell Too Far on Unfortunate News InvestorPlace
Mar-21-19 07:51AM  The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering Benzinga
07:12AM  9 High-Margin Stocks Seen Leading in Fed's New Dovish Era Investopedia
Mar-20-19 04:51PM  Here's Why Cytokinetics Stock Jumped Today Motley Fool
08:30AM  Amgen, Cytokinetics And Servier Announce Continuation Of GALACTIC-HF Following Planned Interim Analysis PR Newswire
08:30AM  Amgen, Cytokinetics and Servier Announce Continuation of GALACTIC-HF Following Planned Interim Analysis GlobeNewswire
Mar-18-19 06:59PM  Regeneron, Sanofi Get EC Nod for Label Expansion of Praluent Zacks
09:22AM  Spectrum Pharma (SPPI) Withdraws Rolontis BLA, Shares Down Zacks
Mar-17-19 07:31AM  Better Buy: Amgen vs. Gilead Sciences Motley Fool
Mar-15-19 04:25PM  Stocks Close Up on Signs of Progress in U.S.-China Trade Talks, Boeing Higher
04:24PM  Can Amgen Leapfrog A Key Rival And Add Millions Of New Patients? Investor's Business Daily
04:04PM  Roche Gets Approval for Label Expansion of MabThera in Europe Zacks
04:00PM  Amgen Announces New Four-Year Outcomes Study To Examine Long-Term Effects Of Repatha® (evolocumab) In High-Risk Cardiovascular Disease (CVD) Patients Without Prior Heart Attack Or Stroke PR Newswire
Mar-14-19 10:36AM  Roche Receives EC Approval for Label Expansion of Hemlibra Zacks
05:01AM  Blue Chip Drug Stocks Face 'Reckoning' on Future Downgrades Investopedia
Mar-13-19 08:37AM  FDA medical adviser: 'Congress is owned by pharma' Yahoo Finance
Mar-12-19 10:50AM  Pfizer's Herceptin Biosimilar Trazimera Gets FDA Approval Zacks
09:55AM  Roche's (RHHBY) Tecentriq Gets FDA Approval for Breast Cancer Zacks
09:29AM  Amgen and Jay Leno Partner to Sound the Alarm on High Cholesterol and its Link to Heart Attack and Stroke in Patients Most at Risk PR Newswire
Mar-11-19 09:45AM  Is Amgen (AMGN) a Profitable Pick ForValue Investors Now? Zacks
Mar-10-19 05:19PM  Better Buy: Amgen vs. Biogen Motley Fool
Mar-08-19 04:32PM  Could A Patent Battle Force Sanofi To Snap Up This Biotech Stock? Investor's Business Daily
Mar-07-19 04:05PM  Amgen Announces 2019 Second Quarter Dividend PR Newswire
04:00PM  Amgen To Present At The Cowen and Company 39th Annual Healthcare Conference PR Newswire
Mar-06-19 04:00PM  New Data From Amgen To Be Presented At ACC.19 Continues To Build Evidence For Repatha® (evolocumab) Across Multiple Patient Populations PR Newswire
11:34AM  Lilly's Emgality Gets FDA Priority Review for Cluster Headache Zacks
09:05AM  Ligand Sells Promacta Rights for $827M, Updates '19 View Zacks
08:40AM  Here are three stocks that are trading at a discount CNBC Videos
08:16AM  3 Big Pharmas Trying to Pop the Rebate Bubble Motley Fool
07:56AM  Amgen Inc. (NASDAQ:AMGN): Poised For Long-Term Success? Simply Wall St.
07:42AM  Amgen Falls 3%
06:28AM  Biotech Companies Slump Midday With FDA Chief Set to Leave
Mar-05-19 06:57PM  U.S. FDA chief tough on e-cigs steps down in surprise resignation Reuters
08:42AM  Merck Gets CHMP Nod for Six-Week Dosing Option of Keytruda Zacks
07:30AM  New Research: Key Drivers of Growth for Marsh & McLennan Companies, Conagra Brands, Amgen, Emerson Electric, Polaris Industries, and Hologic Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It offers products for the treatment of oncology/hematology, cardiovascular, inflammation, bone health, and neuroscience. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, a pegylated protein to treat cancer patients; Prolia to treat postmenopausal women with osteoporosis; Aranesp to treat anemia; Xgeva for skeletal-related events prevention; Sensipar/Mimpara products to treat sHPT in chronic kidney disease; and EPOGEN to treat a lower-than-normal number of red blood cells. It also markets other products in various markets, including Kyprolis, Nplate, Vectibix, Repatha, NEUPOGEN, Parsabiv, Blincyto, Aimovig, Imlygic, Corlanor, Kanjintitm, and Amgevitatm. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaborative agreements with Novartis; UCB; Bayer HealthCare Pharmaceuticals Inc.; and DaVita Inc. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SUGAR RONALD DDirectorApr 03Option Exercise54.712,000109,42015,092Apr 03 06:27 PM
SUGAR RONALD DDirectorApr 03Sale193.182,000386,36013,092Apr 03 06:27 PM
SUGAR RONALD DDirectorMar 06Option Exercise54.712,000109,42014,988Mar 08 07:47 PM
SUGAR RONALD DDirectorMar 06Sale188.882,000377,76012,988Mar 08 07:47 PM
SUGAR RONALD DDirectorFeb 07Option Exercise54.712,000109,42014,988Feb 11 09:27 PM
SUGAR RONALD DDirectorFeb 07Sale190.002,000380,00012,988Feb 11 09:27 PM
Jacks TylerDirectorDec 06Option Exercise82.6020,0001,652,00028,979Dec 10 08:46 PM
Jacks TylerDirectorDec 06Sale195.4120,0003,908,2328,979Dec 10 08:46 PM
Piacquad DavidSVP, Business DevelopmentNov 30Option Exercise54.696,500355,48545,128Dec 03 08:13 PM
Patton Cynthia MSVP & CCONov 29Option Exercise54.691,77797,18423,090Dec 03 08:11 PM
Patton Cynthia MSVP & CCONov 29Sale202.881,777360,52021,313Dec 03 08:11 PM
HENDERSON REBECCA MDirectorAug 10Option Exercise63.113,000189,33016,197Aug 14 08:29 PM
Harper Sean EEVP, Research & DevelopmentJul 16Sale195.711,525298,45856,082Jul 16 08:20 PM
Harper Sean EEVP, Research & DevelopmentJun 12Sale184.271,525281,01257,510Jun 12 07:07 PM
Harper Sean EEVP, Research & DevelopmentMay 14Sale174.101,525265,50359,035May 15 07:52 PM
Piacquad DavidSVP, Business DevelopmentMay 11Option Exercise54.7115,000820,65051,566May 15 07:55 PM